228 related articles for article (PubMed ID: 29393482)
1. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
Li X; Moon G; Shin S; Zhang B; Janknecht R
Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
4. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
[TBL] [Abstract][Full Text] [Related]
5. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
6. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
[TBL] [Abstract][Full Text] [Related]
7. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
Kim TD; Shin S; Janknecht R
Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
[TBL] [Abstract][Full Text] [Related]
8. Diversity within the JMJD2 histone demethylase family.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Feb; 353(4):973-7. PubMed ID: 17207460
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of JMJD2 family genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jun; 24(6):1623-8. PubMed ID: 15138608
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.
Kim TD; Oh S; Shin S; Janknecht R
PLoS One; 2012; 7(4):e34618. PubMed ID: 22514644
[TBL] [Abstract][Full Text] [Related]
12. Identification of non-histone substrates for JMJD2A-C histone demethylases.
Ponnaluri VK; Vavilala DT; Putty S; Gutheil WG; Mukherji M
Biochem Biophys Res Commun; 2009 Dec; 390(2):280-4. PubMed ID: 19799855
[TBL] [Abstract][Full Text] [Related]
13. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.
Katoh Y; Katoh M
Int J Mol Med; 2007 Aug; 20(2):269-73. PubMed ID: 17611647
[TBL] [Abstract][Full Text] [Related]
14. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
Berry WL; Janknecht R
Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
[TBL] [Abstract][Full Text] [Related]
15. Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d.
Chandwani R; Fang TC; Dewell S; Tarakhovsky A
Front Immunol; 2023; 14():1146699. PubMed ID: 37275914
[TBL] [Abstract][Full Text] [Related]
16. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
Nakagawa T; Sato Y; Tanahashi T; Mitsui Y; Kida Y; Fujino Y; Hirata M; Kitamura S; Miyamoto H; Okamoto K; Muguruma N; Bando Y; Takayama T
Gastric Cancer; 2020 May; 23(3):426-436. PubMed ID: 31677131
[TBL] [Abstract][Full Text] [Related]
17. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase.
Sinha KM; Yasuda H; Coombes MM; Dent SY; de Crombrugghe B
EMBO J; 2010 Jan; 29(1):68-79. PubMed ID: 19927124
[TBL] [Abstract][Full Text] [Related]
19. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
Li Y; Wang Y; Xie Z; Hu H
Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
Berry WL; Shin S; Lightfoot SA; Janknecht R
Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
